Fig. 1
From: Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease
The correlations of CD19+CD24−CD38hi plasmablasts/plasma cells with clinical and laboratory parameters. a Gating strategy of CD19+CD24−CD38hi plasmablasts/plasma cells. Correlations of the ratio of CD19+CD24−CD38hi plasmablasts/plasma cells and serum (b) immunoglobulin G4 (IgG4), (d) erythrocyte sedimentation rate (ESR), (e) IgG, (f) IgE, (g) C-reactive protein (CRP), and (h) involved organs are shown. c Correlation of the absolute number of CD19+CD24−CD38hi plasmablasts/plasma cells and serum IgG4. SSC Side scatter